The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Pharmacotherapy for anxiety disorders in children and adolescents
Open accessAbstract
Anxiety disorders are the most common mental health diagnoses in youth, and carry risks for ongoing impairments and subsequent development of other psychiatric comorbidities into adulthood. This article discusses considerations for assessment and treatment of anxiety disorders in youth, with a focus on the evidence base of pharmacologic treatment and important clinical considerations to optimize care. We then briefly describe the impact of anxiety on neuronal elements of fear circuitry to highlight how treatments may ameliorate impairments through enhanced plasticity Overall, pharmacotherapy for anxiety disorders is effective in improving clinical symptoms, particularly in combination with psychotherapy. Response is typically seen within several weeks, yet longitudinal studies are limited. Selective serotonin reuptake inhibitors are thought to be relatively safe and effective for acute treatment of several classes of anxiety disorders in youth, with increasing evidence supporting the role of neuronal plasticity in recovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“On the contrary, benzodiazepines and tricyclic antidepressants were not effective at promoting a decrease in anxiety symptoms.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [35]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, research on these medications for this population is limited, and their use is generally not preferred over SSRIs and SNRIs and should only be used with great caution and close monitoring in this population because of the adverse side effect profile [31,34,35].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In general, meta-analyses and reviews have demonstrated that CBT is more effective in treating SAD compared to waitlist controls, treatment as usual and placebo conditions [32,35].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In sum, our review of the literature suggests that despite the efficacy of SSRIs for pediatric SAD, psychotherapy alone or in combination with pharmacological treatment is the preferred treatment approach because it poses less risk of causing adverse effects and dropout [35,45].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When sertraline and CBT are combined as a treatment, it is more effective than any other monotherapeutic treatment modality alone at decreasing anxiety symptoms and improving response rates.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [35]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318179964f · Cited by 3,399
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889
The Neurocircuitry of Fear, Stress, and Anxiety Disorders
Shin, L. M., & Liberzon, I. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.83 · Cited by 2,083
ADULT NEUROGENESIS IN THE MAMMALIAN CENTRAL NERVOUS SYSTEM
Ming, G.-L., & Song, H. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.051804.101459 · Cited by 1,839
Enriched environments, experience-dependent plasticity and disorders of the nervous system
Nithianantharajah, J., & Hannan, A. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1970 · Cited by 1,771
Stress, memory and the amygdala
Roozendaal, B., McEwen, B. S., & Chattarji, S. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2651 · Cited by 1,760
Vyas, A., Mitra, R., Shankaranarayana Rao, B. S., & Chattarji, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06810.2002 · Cited by 1,662
Research works printed but not linked: 22
- Irwin C., 2002, Rudolph's Pediatrics. 21st ed. New York, NY: McGraw Hill;, 234
- Rockhill CM., 2010, Curr Probl Pediatr Adolesc Health Care., 40, 67
- Chiang O., 2007, Mosby's Pediatric Clinical Advisor: Instant Diagnosis and Treatment. 2nd ed. St. Louis, MO: Mosby, Inc;
- Varley C., 2006, Behavioral Pediatrics. 2nd ed. New York, NY: iUniverse, Inc;., 618
- Pine DS., 2002, J Ami Acad Child Adolesc Psychiatry., 12, 189
- Ipser JC., 2009, Cochrane Database Syst Rev., CD005170
- Kendall P., 2006, Cognitive-Behavioral Therapy for Anxious Children: Therapist Manual. 3rd ed. Ardmore, PA: Workbook Publishing;
- Stein DJ., 2009, CNS Spectr., 14, 25
- Cohen JA., 2010, J Am Acad Child Adolesc Psychiatry., 49, 414
- Singh T., 2009, Psychiatry (Edgemont)., 6, 30
- Gittelman-Klein R., 1971, Calif Med., 115, 42
- Flament MF., 1985, Psychopharrnacol Bull., 21, 150
- Longo L., 2000, Am Fam Physician., 61, 2121
- Perry B., 2008, The Boy Who Was Raised as a Dog and Other Stories from a Child Psychiarist's Notebook - What Traumatized Children Can Teach Us About Loss, Love, and Healing. New York, NY: Basic Books;
- Harmon R., 1999, J Natl Med Assoc., 91, 475
- Kovacs M., 1998, J Child Psychol Psychiatry., 39, 47, 10.1111/1469-7610.00303 · doi:10.1111/1469-7610.00303 · Paper page
- Kendall P., 2006, Anxiety Disorders. New York, NY: Guilford Press;, 259
- Clark DB., 1998, Alcohol Health Res World., 22, 117
- Field B., 2009, Autism Examiner.
- Lewin A., 2009, Depiess Anxiety., 26, 521
- Eiland L., Hippocampus. In press.
- Malberg JE., 2004, J Psychiatry Neurosci., 29, 196
Cited by
Behavioural and emotional disorders in childhood: A brief overview for paediatricians
Ogundele, M. O. (2018) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v7.i1.9 · Cited by 471
Wolff, A., Joshi, R. K., Ekström, J., Aframian, D., Pedersen, A. M. L., Proctor, G., Narayana, N., Villa, A., Sia, Y. W., Aliko, A., et al. (2017) · Drugs in R&D · doi:10.1007/s40268-016-0153-9 · Cited by 364
Cohen Kadosh, K., Muhardi, L., Parikh, P., Basso, M., Jan Mohamed, H. J., Prawitasari, T., Samuel, F., Ma, G., & Geurts, J. M. W. (2021) · Nutrients · doi:10.3390/nu13010199 · Cited by 159
Hippocampal HDAC4 Contributes to Postnatal Fluoxetine-Evoked Depression-Like Behavior
Sarkar, A., Chachra, P., Kennedy, P., Pena, C. J., Desouza, L. A., Nestler, E. J., & Vaidya, V. A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.73 · Cited by 79
Askari, S., & Salpekar, J. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00080-9 · Cited by 74
Metadata
- Authors
- Kodish, I., Rockhill, C., & Varley, C.
- Affiliations
- University of Washington (US)
- Corresponding author
- Kodish, Ian
- Venue
- Dialogues in Clinical Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2011-12-31
- Volume
- 13
- Issue
- 4
- Pages
- 439-452
- ISSN
- 1294-8322 (ISSN-L)
- 1958-5969
- PMC
- PMC3263391
- OpenAlex
- W2952704118
- Cited by
- 62
- References
- 120
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 4 · 2023: 4 · 2022: 1 · 2021: 6 · 2020: 5 · 2019: 8 · 2018: 4 · 2017: 3 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 1 · 2012: 2
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Dialogues in Clinical Neuroscience (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- anxiety disorders, children and adolescents, pharmacotherapy, selective serotonin reuptake inhibitors, fear circuitry, neuroplasticity, psychotherapy, psychiatric comorbidity, treatment response
- MeSH terms
- Adolescent, Anxiety Disorders, Child, Humans, Neuronal Plasticity, Anti-Anxiety Agents, Selective Serotonin Reuptake Inhibitors, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacotherapy for anxiety disorders in children and adolescents. https://app.cochat.ai/papers/10.31887/dcns.2011.13.4/ikodish
- The paper
- Kodish, I., Rockhill, C., & Varley, C. (2011). Pharmacotherapy for anxiety disorders in children and adolescents. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2011.13.4/ikodish
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.